Effects of dexmedetomidine nasal spray combined with propofol for deep sedation in patients undergoing endoscopic retrograde cholangiopancreatography: a prospective randomized study
Frontiers in Medicine · 07.05.2026 · 13
DOI: 10.3389/fmed.2026.1832298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 07.05.2026. Verfasst von Jie Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2021 Outstanding Young Doctor Award, Key Discipline of Digestive Endoscopy at Dongfang Hospital, Clinical Peak Discipline of Digestive Diseases.
Abstract (Originalsprache)
Background
Endoscopic retrograde cholangiopancreatography (ERCP) requires effective and safe deep sedation. Dexmedetomidine is a promising sedative in painless procedures. This study investigated the efficacy and safety of preoperative dexmedetomidine via nasal spray and conventional intravenous infusion for ERCP deep sedation.
Methods
In this single-center, prospective randomized trial, 180 adult patients scheduled for ERCP were assigned to three groups: preoperative nasal spray (Group NS), intravenous pumping (Group IP), or control without dexmedetomidine (Group C). A propofol-based protocol was applied to all groups. Primary outcome was the incidence of intraoperative hypoxemia. Secondary outcomes included propofol consumption, hemodynamic stability, recovery profiles, and the incidence of other adverse events.
Results
Compared to Group C, both Group NS and Group IP significantly reduced intraoperative hypoxemia (5.0% vs. 5.0% vs. 21.7%, p < 0.001), lowered propofol requirements, and improved postoperative recovery (shorter time to consciousness, lower agitation and pain scores). Group NS achieved comparable clinical benefits to Group IP but with significantly shorter anesthesia time (48.9 ± 5.2 min vs. 59.7 ± 6.4 min, p < 0.001) and higher endoscopist satisfaction (9 (9, 10) vs. 8 (7, 8), p < 0.001).
Conclusion
Dexmedetomidine nasal spray combined with propofol is as effective and safe as the intravenous route for ERCP deep sedation, offering the additional advantages of shorter anesthesia duration and greater procedural convenience. Clinical trial registration https://register.clinicaltrials.gov , identifier NCT07204106.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Clinical Laboratory, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Förderung
- 2021 Outstanding Young Doctor Award
- Key Discipline of Digestive Endoscopy at Dongfang Hospital
- Clinical Peak Discipline of Digestive Diseases
- Dietary Endoscopy Early Tumor Endoscopic Diagnosis and Treatment
Zitieren
APA
Wu, J., Liu, J., Xu, X., He, K., Wei, S., Chen, T., & Yang, X. (2026). Effects of dexmedetomidine nasal spray combined with propofol for deep sedation in patients undergoing endoscopic retrograde cholangiopancreatography: a prospective randomized study. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1832298
Vancouver
Wu J, Liu J, Xu X, He K, Wei S, Chen T, et al. Effects of dexmedetomidine nasal spray combined with propofol for deep sedation in patients undergoing endoscopic retrograde cholangiopancreatography: a prospective randomized study. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1832298
BibTeX
@article{Wu2026,
author = {Wu, Jie and Liu, Jiesong and Xu, Xiaocao and He, Kan and Wei, Shiyou and Chen, Tao and Yang, Xiaohu},
title = {Effects of dexmedetomidine nasal spray combined with propofol for deep sedation in patients undergoing endoscopic retrograde cholangiopancreatography: a prospective randomized study},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1832298}
}
EUVIMED